Week 1 HW: Principles and Practices
I found myself very interested in the aspect of biosynthesis and engineering fabric-like material from microorganisms. The example shown in the first lecture of jackets made from bacterial cellulose piqued my curiosity in particular because it involves possibly making clothes from sustainable and biodegradable material instead of plastic. As a biology student, this application opened my eyes to a new and exciting path I could take in the future that is independent from medicinal applications. For now, I’m very curious about it. But hopefully, I will be able to make this my final project and get hands on experience in synthesizing such materials.
I view biosynthesizing fabric-like materials as an alternative to traditional methods that use plastics/nonbiodegradable materials. The traditional method contributes significantly to pollution and harms the environment. A governance goal would be to ensure that this technology is actually capable of reducing environmental harm when produced for industrial use. A sub goal can be verifying sustainability claims through experimental evidence and making sure the production process is safe for both the ecosystem and the workers. If this field is developed enough to find a way to scale this for industrial use, it could be a real game changer in the fashion industry while lessening environmental risks.
Ensuring biosynthesized materials are developed responsibly requires several governance actions that can be implemented by different major actors.
An important, and perhaps a primary, actor would be government and regulatory agencies. These organizations are capable of establishing biosafety rules that require laboratories to safely handle engineered microorganisms used in biofabrication. These rules aim to prevent accidents and protect public safety. These regulations involve creating a standardized process about containment and waste management that institutes must follow to receive licensing. The assumption here is that the companies would comply and strictly enforce the regulations. It could very well fail if the instructions are loosely enforced or, on the contrary, are too strict and restrictive, which might slow the creative process.
The second actor is biotech and fashion companies. These companies can contribute by implementing sustainable production practices as well as providing transparent information about their products. Advertising also plays a major role in how the customers would perceive this new invention. The purpose is for consumers to be aware of what they are purchasing, this can further raise awareness about the existence of a more ecofriendly way of consuming. This governance assumes multiple things; that the companies prioritize ethical responsibilities and that consumers will respond positively to the nature of biosynthesized products. A potential risk is that companies may lean towards misinformation, exaggerating or poorly marketing their products.
The third actor are universities and researchers. Researchers can study and evaluate the true environmental impact of biosynthesized materials; this would provide more concrete evidence that they’re safe for the environment as well as potentially developing a safer version of engineered microorganisms. The purpose is to provide reliable scientific evidence to act as a guide for industrial use. This assumes the willingness to fund the research and provided ethical supervision. A risk may be limited funding given the scale and material this kind of research requires.
+------------------------+---+---+---+---+---+---+---+---+---+
| |Regulatory| Biotech |Researchers|
| |SS AB MC DN SP PF RB EG TR |
+------------------------+---+---+---+---+---+---+---+---+---+
ENHANCE BIOSECURITY
Prevent incidents | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 1 | 3 |
Help respond | 2 | 2 | 1 | 3 | 2 | 3 | 2 | 2 | 3 |
FOSTER LAB SAFETY
Prevent incidents | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 1 | 2 |
Help respond | 2 | 2 | 1 | 3 | 2 | 3 | 2 | 2 | 2 |
PROTECT ENVIRONMENT
Prevent incidents | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 3 |
Help respond | 2 | 2 | 1 | 3 | 2 | 2 | 2 | 2 | 3 |
OTHER CONSIDERATIONS
Minimize cost/burden | 2 | 3 | 2 | 2 | 3 | 1 | 2 | 2 | 1 |
Feasibility | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 1 |
Not impeding research | 2 | 3 | 2 | 1 | 2 | 1 | 1 | 2 | 1 |
Promote constructive | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 |
Key:
SS = Set safety standards
AB = Approve biomaterials
MC = Monitor companies
DN = Develop new fibers
SP = Scale production
PF = Partner fashion
RB = Research bio processes
EG = Experiment genetics
TR = Train researchers
(sorry, i made my original chart in Word. i couldnt transfer it here and i had trouble inserting an image so i used chatgpt to convert it to text.)
- Based on the scoring, I would prioritize the actions that must be taken by regulatory agencies and biotech companies. They establish clear biosafety and clarify the environmental impact, all essential to ensuring that biosynthetic fabrics are produced in a safe and responsible manner. Biotech companies develop and scale products is necessary because without industry involvement this technology cannot become easily accessible to the masses. These actions balance creativity, engineering and safety, contributing to the field growth while minimizing environmental risks. a potential trade off is that strict regulations may slow the researching process and increase production costs. and because this is still a developing field, there is no garanty about its long term impact on the enviroment. an ethical concern i found in the topics covered during the lecture would be automating protein monitoring. though it is much faster than humans, it is susceptible to error and biases. governance actions to address this concern maintaining regular human reveiewing to ensure no errors or contamination goes unnoticed.